Hessel H. Van Der Zee

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials.

Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials.

Journal: Nature medicine

Published: May 28, 2026

Bimekizumab 2-year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results.

Bimekizumab 2-year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 25, 2026

Criteria for Hidradenitis Suppurativa Competence Centers.

Criteria for Hidradenitis Suppurativa Competence Centers.

Journal: Dermatology and therapy

Published: March 20, 2026

Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach.

Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach.

Journal: JAMA dermatology

Published: November 26, 2025

Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.

Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.

Journal: JAMA dermatology

Published: August 27, 2025

Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativa.

Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativa.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 24, 2025

Hidradenitis suppurativa; a condition with multiple phenotypes

Hidradenitis suppurativa; a condition with multiple phenotypes

Journal: Nederlands tijdschrift voor geneeskunde

Published: July 29, 2025

Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) study.

Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) study.

Journal: The British journal of dermatology

Published: July 17, 2025

Patients' Preference Regarding Patient-Reported Outcome Measures for Hidradenitis Suppurativa: A Cross-Sectional Multicenter Study.

Patients' Preference Regarding Patient-Reported Outcome Measures for Hidradenitis Suppurativa: A Cross-Sectional Multicenter Study.

Journal: Dermatology (Basel, Switzerland)

Published: April 23, 2025

Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics.

Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 11, 2025

Metformin in conjunction with doxycycline is not superior to doxycycline monotherapy for hidradenitis suppurativa; results of a phase III double-blinded randomized placebo- controlled trial.

Metformin in conjunction with doxycycline is not superior to doxycycline monotherapy for hidradenitis suppurativa; results of a phase III double-blinded randomized placebo- controlled trial.

Journal: The British journal of dermatology

Published: April 10, 2025

Towards a Paradigm Shift in Delivering Hidradenitis Suppurativa Care: a Narrative Review.

Towards a Paradigm Shift in Delivering Hidradenitis Suppurativa Care: a Narrative Review.

Journal: Dermatology and therapy

Published: March 25, 2025

Showing 1-12 of 91

Last Updated: 09/26/2026